SignalPoint Asset Management’s Clover Health Investments CLOV Stock Holding History

SignalPoint Asset Management’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$504K	Buy	160,074 +9,390	+6%	+$33.6K	0.12%	133
2024 Q3	$425K	Buy	150,684 +11,318	+8%	+$25.9K	0.1%	169
2024 Q2	$171K	Hold	139,366	–	–	0.05%	252
2024 Q1	$111K	Buy	139,366 +40,000	+40%	+$36.4K	0.03%	243
2023 Q4	$94K	Buy	99,366 +400	+0.4%	+$393	0.03%	222
2023 Q3	$107K	Buy	98,966 +12,000	+14%	+$14.3K	0.03%	207
2023 Q2	$78K	Buy	86,966 +13,500	+18%	+$12K	0.02%	209
2023 Q1	$62K	Buy	73,466 +3,000	+4%	+$3.28K	0.02%	217
2022 Q4	$65K	Hold	70,466	–	–	0.02%	214
2022 Q3	$119K	Buy	70,466 +7,200	+11%	+$18.9K	0.05%	201
2022 Q2	$135K	Buy	63,266 +12,125	+24%	+$32.2K	0.05%	206
2022 Q1	$182K	Buy	51,141 +10,225	+25%	+$29.6K	0.06%	221
2021 Q4	$152K	Buy	40,916 +3,150	+8%	+$19.3K	0.05%	232
2021 Q3	$279K	Buy	37,766 +7,100	+23%	+$60.8K	0.09%	178
2021 Q2	$408K	Buy	+30,666	New	+$301K	0.13%	151

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

SignalPoint Asset Management's CLOV Position: Q4 2024 in Review

SignalPoint Asset Management increased its Clover Health Investments (CLOV) stake by 6.2% in Q4 2024, buying an estimated $33.6K and bringing the position to 160,074 shares worth $504K. The position accounts for 0.12% of the portfolio, ranked #133.

SignalPoint Asset Management first reported a position in CLOV in Q2 2021 and has held it in 15 quarters since. 178 funds tracked by Wall St. Rank hold CLOV as of Q4 2024.

SignalPoint Asset Management held 160,074 shares of Clover Health Investments worth $504K as of Q4 2024.
SignalPoint Asset Management bought 9,390 Clover Health Investments shares in Q4 2024, an estimated $33.6K.
Clover Health Investments made up 0.12% of SignalPoint Asset Management's portfolio in Q4 2024, its #133 holding.
SignalPoint Asset Management first reported a position in Clover Health Investments in Q2 2021 and has held it in 15 quarters since.
178 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2024.

Based on SignalPoint Asset Management's 13F filing for Q4 2024, filed 14 Jan 2025.